Skip to content
Riskpilot
← Back to search
Sign in
Get full access
LobSor Pharmaceuticals Aktiebolag
AB
Active
Org 5569304768
Kålsängsgränd 10 D, 753 19
Uppsala
Manufacture of pharmaceutical preparations
· NACE 2120
Est. 2013
3 employees
Watchlist
Share
Sweden
/
Companies
/
Manufacture of pharmaceutical preparations
/
LobSor Pharmaceuticals Aktiebolag
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
EC
Eva Charlotte Freiman Börnke
Chief Executive Officer
Chief Executive Officer
2021
AH
Anna Hélène Maria Westberg
Chief Auditor
Chief Auditor
2020
Former (2)
PG
Per Gustaf Hammar
Chief Auditor
Chief Auditor
2020 – 2020
UL
Ulf Lennart Rosén
Chief Executive Officer
Chief Executive Officer
2020 – 2021
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
DB
Daniel Buschmann
Chairman
2025
FJ
Felix Johann Vitus von Berg
Deputy Board Member
2020
Former (9)
IL
Inge-Merete Larsen
Chairman
2020 – 2021
SW
Steffen Wagner
Chairman
2021 – 2022
MB
Margareth Birgitta Jorvid
Board of Directors
2020 – 2020
PO
Peter Olof Holmstedt
Board of Directors
2020 – 2020
BK
Birgitta Kristina O Lundvik
Chairman
2020 – 2020
GS
Gunnar Stefan Åsberg
Board of Directors
2020 – 2020
CE
Cigdem Erek
Chairman
2025 – 2025
FF
Fredrik Franz Johan W. Buch
Deputy Board Member
2020 – 2020
HB
Holger Buschmann
Chairman
2022 – 2025
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on LobSor Pharmaceuticals Aktiebolag
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network